Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1615/CritRevImmunol.2020034943

http://scihub22266oqcxt.onion/10.1615/CritRevImmunol.2020034943
suck pdf from google scholar
32749095!ä!32749095

suck abstract from ncbi

pmid32749095      Crit+Rev+Immunol 2020 ; 40 (2): 173-184
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • MAIT Cells in COVID-19: Heroes, Villains, or Both? #MMPMID32749095
  • Haeryfar SMM
  • Crit Rev Immunol 2020[]; 40 (2): 173-184 PMID32749095show ga
  • Mucosa-associated invariant T cells (MAIT cells) are unconventional, innate-like T lymphocytes with remarkable effector and immunoregulatory functions. They are abundant in the human peripheral blood and also enriched in mucosal layers and in the lungs, SARS-CoV-2's main ports of entry. Once activated, MAIT cells produce inflammatory cytokines and cytolytic effector molecules quickly and copiously. MAIT cells are best known for their antibacterial and antifungal properties. However, they are also activated during viral infections, typically in a cytokine-dependent manner, which may promote antiviral immunity. On the other hand, it is plausible to assume active roles for MAIT cells in infection-provoked cytokine storms and tissue damage. SARS-CoV-2 infection may be asymptomatic, mild, severe, or even fatal, depending on sex, age, the presence of preexisting morbidities, and the individual's immunological competence, or lack thereof, among other factors. Based on the available literature, I propose that MAIT cells regulate the host response to SARS-CoV-2 and constitute attractive targets in the prevention or clinical management of coronavirus disease 19 (COVID-19) and some of its complications. Unlike mainstream T cells, MAIT cells are restricted by a monomorphic antigen-presenting molecule called MHC-related protein 1 (MR1). Therefore, MR1 ligands should modify MAIT cell functions relatively uniformly in genetically diverse subjects and may be tested as immunotherapeutic agents or vaccine adjuvants in future studies.
  • |Betacoronavirus/*immunology[MESH]
  • |CD4-Positive T-Lymphocytes/immunology[MESH]
  • |CD8-Positive T-Lymphocytes/immunology[MESH]
  • |COVID-19[MESH]
  • |Coronavirus Infections/*immunology/pathology[MESH]
  • |Cytokines/immunology[MESH]
  • |Histocompatibility Antigens Class I/*metabolism[MESH]
  • |Humans[MESH]
  • |Minor Histocompatibility Antigens/*metabolism[MESH]
  • |Mucosal-Associated Invariant T Cells/*immunology/metabolism[MESH]
  • |Pandemics[MESH]
  • |Pneumonia, Viral/*immunology/pathology[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box